Cummins and colleagues treated six patients with r/r AML with CD123 CAR T-cells created by mRNA electroporation and demonstrated a good safety profile, noting only mild fevers and low-grade CRS [30]. The gene discussed is IL3RA; the disease is acute myeloid leukemia.